HEMATOTOXIC ADVERSE DRUG REACTIONS ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS AND CYTOTOXIC DRUGS IN THE TREATMENT OF GLIOBLASTOMA: A SYSTEMATIC REVIEW

HEMATOTOXIC ADVERSE DRUG REACTIONS ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS AND CYTOTOXIC DRUGS IN THE TREATMENT OF GLIOBLASTOMA: A SYSTEMATIC REVIEW

Several studies have shown that the use of inhibitors of vascular endothelial growth factor (Vascular Endothelial Gowth Factor, VEGF) in the treatment of glioblastoma results in a significant increase in the rate of progression-free survival. However, administration of anti-VEGF agents is associated...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Stepanov, M. A. Shameeva, D. B. Kruchinin, V. A. Byvaltsev, I. A. Shagdurova
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2020-10-01
Series:Сибирский онкологический журнал
Subjects:
glioblastoma
antiangiogenic therapy
cytotoxic drugs
adverse drug reactions
hematotoxicity
Online Access:https://www.siboncoj.ru/jour/article/view/1587
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items